Synlogic (SYBX)
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases...
- Open
- 1.110
- High
- 1.160
- Low
- 1.110
- Prev. Close
- 1.120
- Volume
- 4.29K
- Turnover
- 4.77K
- Avg Price
- 1.112
- Bid/Ask Ratio
- --
- Amplitude
- 4.46%
- 52wk High
- 1.870
- Volume Ratio
- 4.61
- Turnover Ratio
- 0.11%
- 52wk Low
- 0.540
- Float Mkt Cap
- 4.48M
- Market CapUSD
- 13.60M
- P/ETTM
- Loss
- P/EDynamic
- 49.26
- P/EStatic
- --
- EPSTTM
- -0.0535
- EPSDynamic
- 0.0225
- EPSStatic
- --
- BVPS
- 0.98
- P/B
- 1.13
- Circulating Supply
- 4.03M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 12.25M
- Min lot size
- 1
- Currency
- USD
Synlogic Analyst Rating
View moreForecast & Rating
Aug 16, 2024Price forecast
$1.00-9.91%
Forecast & RatingHold
1analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · Aug 29 at 02:51 PM
10:50 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of the Merger - BWMN, SUNS, DV and SYBX
- PUBT · Aug 11 at 08:34 PM
Synlogic berbalik ke laba bersih USD 138.000 pada 6 bulan pertama FY26
- MorningStar · Aug 10 at 02:58 PM
SYBX Stock Alert: Halper Sadeh LLC is Investigating Whether Synlogic, Inc. is Obtaining a Fair Price for its Shareholders
- Pharmaceutical Technology · Jul 30 at 09:00 AM
Synlogic and Caldera sign merger agreement
